Novartis highlights new findings in advancing care for patients with 170 ... FierceBiotech Clinical data from multiple compounds will be featured at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) including Afinitor® (everolimus), Tasigna® (nilotinib) and the pipeline compound LDK3781. The 18th Congress of the ... NOVARTIS AG : Novartis highlights new findings in advancing care for patients ... |
